# Rabies vaccine

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/rabies-vaccine
Canonical HTML page: https://getbiobrief.com/entity/rabies-vaccine

## Recent coverage (1 stories)

### Rabies Vaccine Use Up 33%, HRIG Up 76% in 2026
2026-09-12 07:06:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Biotech and pharma stakeholders see CDC data showing a 17% rise in rabies exposure inquiries translating into 33% higher vaccine utilization and 76% higher HRIG utilization. The trend signals demand pressure for post-exposure prophylaxis biologics.
Full story: https://getbiobrief.com/story/rabies-biologics-demand-surge-2026-cdc

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.